Xenical 120 mg hard capsules clinical trials

Control Of BioEquivalence with Xenical (COBEX): A Phase I, randomized, active-control study to evaluate EMP22 pharmacodynamics and EMP16 pharmacokinetics versus Xenical® in healthy volunteers.

This study is comparing two new medicines (EMP22 and EMP16) for obesity with an existing one (Xenical). We want to see how much fat is passed in your poo when taking these medicines. It's a first step to understand how they work in healthy adults.